Adverse Drug Reaction
Tysabri safety evaluation complete; no new confirmed cases of PML
Published in Clinical Trials Week, November 14th, 2005
The companies have previously reported that findings from their safety evaluation of Tysabri in patients with multiple sclerosis (MS) resulted in no new confirmed cases of PML. Three confirmed cases of PML were previously reported, two of which were fatal. The Tysabri safety evaluation is now complete.
On September 26, 2005 the companies announced that they submitted a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-11-14)
More Articles from Clinical Trials Week
- Chronic Daily Headache
High-dose Botox shows promise as prophylactic treatment - Clinical Trials
Study shows interferon treatment delays MS onset in patients showing clinical signs - Crohn Disease
Phase II Trial results for treatment of Crohn Disease with Cimzia are positive - Drug Development
Data being analyzed in phase II CoFactor trial in patients with metastatic colorectal cancer - Erectile Dysfunction
Tadalafil effective during thiazide diuretic hypertension therapy - Alcoholism Therapy
Increasing leptin levels precede relapse in detoxified alcoholics - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
